No Data
Coherus BioSciences Is Maintained at Buy by Truist Securities
Coherus BioSciences Is Maintained at Buy by Truist Securities
Express News | Truist Securities Maintains Buy on Coherus BioSciences, Lowers Price Target to $7
Express News | Coherus BioSciences Inc : Truist Securities Cuts Target Price to $7 From $8
Coherus BioSciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
There's been a notable change in appetite for Coherus BioSciences, Inc. (NASDAQ:CHRS) shares in the week since its quarterly report, with the stock down 16% to US$1.90. It looks to have been a d
Coherus BioSciences Is Maintained at Buy by HC Wainwright & Co.
Coherus BioSciences Is Maintained at Buy by HC Wainwright & Co.
Express News | HC Wainwright & Co. Maintains Buy on Coherus BioSciences, Raises Price Target to $12